Mastery EAQ Ch. 10

A  Narcotic analgesics should not be used for more than 24 hours.

B  Patients should request analgesics when the pain level reaches a 3 on a scale of 1 to 10.

C  Pain relief is best obtained by administering analgesics around the clock.

D  Analgesics should be administered as needed to minimize adverse effects.

A  Slow pupil reaction, Excess urination, Change in sputum color

B  Altered consciousness, Excess urination, Change in sputum color

C  Excess urination, Hallucinations, Change in sputum color

D  Hallucinations, Slow pupil reaction, Altered consciousness

A  Placed on a new area, with the old patch still in place

B  Placed on an area after cleaning it

C  Placed on a hairy area

D  Placed on the same place as the old patch

A  Ask the patient to bear the pain until the next scheduled opioid dose.

B  Administer a short-acting opioid and follow the regular opioid schedule for the next dose.

C  Distract the patient for 2 hours by using alternative methods, such as music therapy.

D  Administer the scheduled opioid dose early.

A  “Increase the dose of morphine if there is no relief of pain.”
“Take acetaminophen with the morphine.”

B  “Increase the dose of morphine if there is no relief of pain.”
“Rest before taking the medication.”

C  “Rest before taking the medication.”
“Take acetaminophen with the morphine.”

D  “Drink at least 3 liters of fluid a day.”
“Take an over-the-counter stool softener daily.”

A  Prepare for intubation.

B  Assess arterial blood gases.

C  Administer naloxone.

D  Call the respiratory team stat.

A  Diarrhea

B  Hyperactive bowel sounds

C  Insomnia

D  Sedation

A  “Do not crush the medication.”
“Swallow the medication whole.”
“Do not dissolve the medication in water.”

B  “Do not dissolve the medication in water.”
“Take the medication frequently.”
“Increase the dose if you experience no pain relief.”

C  “Take the medication frequently.”
“Increase the dose if you experience no pain relief.”
“Do not crush the medication.”

D  “Take the medication frequently.”
“Swallow the medication whole.”
“Increase the dose if you experience no pain relief.”

A  Diarrhea

B  Anorexia

C  Cancer

D  Asthma

A  Reassess the patient in an hour.

B  Assess blood gases.

C  Assess the patient’s neurologic status.

D  Administer a narcotic antagonist.

A  Random blood glucose 140 mg/dL

B  Serum bilirubin 3.2 mg/dL

C  Hemoglobin 11.2 g/dL

D  Serum creatinine 0.8 mg/dL

A  Consult the primary health care provider and obtain another drug prescription.

B  Administer 1 mg of morphine and notify the primary health care provider.

C  Administer another 1 mg of morphine and reevaluate the pain scale in 15 minutes.

D  Hold the drug, record the assessment, and reassess the patient in 1 hour.

A  Protamine sulfate

B  Acetylcysteine

C  Naloxone

D  Methylprednisolone

A  Administer an opioid antagonist.

B  Inform the primary health care provider.

C  Withhold the scheduled opioid dose.

D  Administer the scheduled opioid dose.

A  “I can understand your fears, but there is no risk of paralysis from epidural analgesia.”

B  “There’s no needle. It’s a thin plastic tube in the protective covering of your spinal cord.”

C  “Tell me more about your understanding of how epidural analgesia relieves your pain.”

D  “If you don’t turn, cough, and breathe deeply, you may get pneumonia or other complications.”

A  Naloxone

B  Acetylcysteine

C  Naltrexone hydrochloride

D  Nalbuphine

A  Within a half hour

B  Within 2 hours

C  In 4 hours

D  In 8 hours

A  Heart rate 110 beats/min

B  Respiratory rate 28 breaths/min

C  Pinpoint pupils

D  Blood in urine

A  Initiate resuscitative measures.

B  Administer flumazenil.

C  Prepare intravenous naloxone.

D  Assess the patients’ responsiveness.

A  Circulation

B  Respiratory rate

C  Chemoreceptor trigger zone

D  Cough reflex

A  Vague feeling of anxiety

B  Heart rate 90 beats/min

C  No bowel movement in 72 hours

D  Respiratory rate 12 breaths/min

A  Assess the patient’s electrocardiogram (ECG).

B  Assess the patient for pain.

C  Administer an amphetamine.

D  Administer naltrexone hydrochloride.

A  Assessment of culture reports

B  Questions regarding past history of drug and alcohol use

C  Questions regarding the date of the last flu vaccine

D  Assessment of chronic diseases causing pain

A  Skin rashes, Muscle stiffness, Blurred vision

B  Nausea, Joint pain, Muscle stiffness

C  Joint pain, Skin rashes, Blurred vision

D  Skin rashes, Blurred vision, Nausea

A  “Apply heat over the patch to increase absorption.”

B  “Keep new and used patches away from children.”

C  “Dispose of patches by melting them with a flame.”

D  “Store the patches in the bathroom medicine cabinet.”

A  Binds and causes a response opposite to that of an agonist

B  Binds instead of the agonist and causes analgesia

C  Binds in place of the agonist and causes no response

D  Binds and causes less pain response than an agonist

A  100 mg

B  107 mg

C  125 mg

D  150 mg

A  Superficial pain

B  Somatic pain

C  Deep pain

D  Visceral pain

A  Miosis

B  Dizziness

C  Diarrhea

D  Constipation

A  “This medication is used as a cough suppressant.”

B  “This medication will help your immune system.”

C  “This medication helps open up your airways.”

D  “This medication will help you get rid of mucous.”

A  “Tell me more about your fears.”

B  “Your pain is well controlled now. Why are you so worried?”

C  “Everything will be fine. You will be back to work in about 6 weeks.”

D  “The disability benefit of your insurance plan will help pay your bills.”

A  Heart rate

B  Blood pressure

C  Respiratory rate

D  Mental status

A  Crystalluria

B  Mucosal irritation

C  Electrolyte imbalance

D  Constipation

A  Blurred vision, Decreased hearing, Elevated liver enzymes

B  Blurred vision, Vomiting, Decreased hearing

C  Nausea, Blurred vision, Decreased hearing

D  Nausea, Vomiting, Elevated liver enzymes

A  Change the patch.

B  Administer naloxone.

C  Add a second patch.

D  Call the primary health care provider.

A  1 mg

B  0.8 mg

C  0.4 mg

D  0.5 mg

A  Platelet count

B  Neutrophil count

C  Blood urea nitrogen (BUN) and creatinine levels

D  Aspartate transaminase (AST) and alanine transaminase (ALT) levels

A  Severe liver disease

B  Joint pain

C  Asthma

D  Anemia

A  Somatic pain

B  Visceral pain

C  Superficial pain

D  Deep pain

A  Pain after abdominal surgery

B  Severe pain resulting from cancer metastasis

C  Lower back pain related to lumbar strain

D  Acute migraine

A  Fentanyl

B  Hydromorphone

C  Codeine sulfate

D  Meperidine

A  Sharp

B  Persistent

C  Sudden onset

D  Sympathetic nervous system response

A  Flumazenil

B  Naloxone

C  Methylprednisolone

D  Acetylcysteine

A  To diminish feelings of anxiety

B  To treat ischemic pain

C  To relieve acute and chronic pain

D  To induce a state of unconsciousness

A  Referred pain

B  Vascular pain

C  Phantom pain

D  Neuropathic pain